ArticleLung India : official organ of Indian Chest Society2026
The effects of pulmonary rehabilitation on symptom change and exacerbations in patients with chronic obstructive pulmonary disease: A randomised controlled trial.
Article in Lung India : official organ of Indian Chest Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the protocol: Making pulmonary rehabilitation stick in complex COPD care.Lung India : official organ of Indian Chest Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to investigate the effects of pulmonary rehabilitation on symptom change and exacerbations in patients with chronic obstructive pulmonary disease (COPD).
methodsThis randomised controlled trial enrolled COPD patients from Shangrao Municipal Hospital between June 2022 and June 2024. The patients were randomly allocated to control and pulmonary rehabilitation groups. Data on demographics, pulmonary function, COPD assessment test (CAT) scores, modified Medical Research Council scores, and inhalation therapy regimens were collected. The patients in the pulmonary rehabilitation group were undergoing pulmonary rehabilitation sessions twice weekly for 6 months. The number of exacerbations and CAT scores were recorded during 6 months of intervention period. The minimum clinically important difference (MCID) was defined as a CAT score decrease of ≥2 at 6-month visits from baseline.
resultsA total of 188 patients with COPD were enrolled and randomly allocated to the control and pulmonary rehabilitation groups. There were no significant differences in clinical characteristics between the control and pulmonary rehabilitation groups. Patients in the pulmonary rehabilitation group were more likely to attain MCID and had lower risk of future exacerbations and hospitalizations during 6 months of intervention period than patients in the control group (P < 0.05). Comparison of the exacerbation proportion using a Kaplan-Meier curve revealed that the patients in the pulmonary rehabilitation group had a lower risk of future exacerbations (P < 0.05).
conclusionsPulmonary rehabilitation is effective for improving symptoms and decreasing future exacerbations in COPD patients. A pulmonary rehabilitation program should be recommended for the daily management of COPD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.